News

Global Health Ltd share price gained 2.34% to Rs 1298.7 after the company`s net profit surged by 39.36% to Rs 219.14 crore, while revenue from operations increased 12.65% to Rs 1469.04 crore in Q3FY26 over Q2FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 6.74 lakh crore, gaining 7.97%. It has inched up 5.08% over last one week and retreating 9.59% in last one month while the market capitalization of Global Health Ltd has improved by 3.07% and 7.92% in the same period respectively. Profit before tax (PBT) of Global Health Ltd stood at Rs 294.83 crore in Q3 FY26, expanding by 47.56% year-on-year, and jumping 38.25% quarter-on-quarter. EBITDA came in at Rs 346 crore, rallying 64.04% YoY and surging by 30.94% sequentially. Total expenses posted a minor rise of 7.68% to Rs 1169.75 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 278.68 crore, inching up 8.36% YoY, while employee benefits expense was at Rs 334.61 crore, ticking higher by 4.80% YoY. For the TTM ended FY26, revenue from operations rose 19.44% to Rs 4410.27 crore, while net profit rose by 15.11% to Rs 554.07 crore, compared to previous TTM. EBITDA soared by 82606% to Rs 820.51 crore, and PBT improved 10.47% to Rs 715.02 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 714.39 crore in FY26, as against Rs 623.76 crore in FY25. Global Health Ltd ticked higher by 1.80% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 9.87% during the same period.

Global Health Limited, which operates Medanta hospitals, will close its trading window for share purchases and sales starting October 1, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s code for prevention of insider trading, reopening 48 hours after the unaudited financial results for the second quarter ended September 30, 2026, are released to the stock exchanges.

Global Health Limited, which operates as Medanta, announced the allotment of 3,000 equity shares with a face value of Rs 2 each at a premium of Rs 1,498 per share to its Employee Welfare Trust under the GHL-Employee Long Term Share Based Incentive Plan 2024. The allotment, approved by the company’s Nomination & Remuneration Committee on September 22, 2026, increased the company`s paid-up share capital from Rs 53,77,43,564 divided into 26,88,71,782 equity shares to Rs 53,77,49,564 divided into 26,88,74,782 equity shares, and the shares will rank pari passu with existing equity shares.

Global Health announced that the 22th Annual General Meeting(AGM) of the company will be held on 16 September 2026.

The board of Global Health at its meeting held on 31 July 2026 has approved the revised construction plan of Company`s upcoming hospital at Guwahati thereby increasing the proposed bed capacity from 400 beds to 650 beds.